Medical Foods Market Size, Share, Growth, Trend and Key Brand Analysis Report
by Susan Hill Business ConsultantThe
global medical foods market size is expected to reach USD
27.20 billion by 2025, registering a CAGR of 6.7% from 2019 to 2025, according
to a new report by Grand View Research, Inc. Rising geriatric population and
increasing prevalence of chronic diseases are among the key factors driving the
market. According to the WHO estimates published in February 2018, the
population aged 60 years and above is expected to increase from 12% in 2015 to
22% by 2050. Non-communicable diseases impose a high economic burden on health
systems globally. According to a study conducted by the researchers from
University of Liège, Belgium, the population suffering from sarcopenia in
Europe is expected to increase from 11.1% in 2016 to 12.9% in 2045.
Medical
foods help treat and prevent age-related sarcopenia. Thus, the demand for
medical foods in the management of chronic conditions, such as sarcopenia, is
expected to augment the market development. Moreover, various public and
private initiatives in the field of clinical nutrition is projected to boost the
market further. A number of manufacturers are extending their capabilities in
the sports
nutrition market with various strategic initiatives, such as M&A
and new product launches, to fulfill the escalating demand. For instance, in
May 2016, Hormel Foods introduced HORMEL VITAL CUISINE, a range of Ready-to-Eat
(RTE) meals, whey protein powders, and nutritional shakes. This product line
was specially designed to meet the nutritional requirements of cancer patients.
Further key
findings from the study suggest:
- Orally
administered medical foods accounted for the highest revenue share and are
projected to maintain the dominance in future owing to ease in
administration and their commercial viability
- Enteral
administration is expected to witness the fastest CAGR of 7.2% over the
forecast period
- Diabetic
neuropathy held the largest revenue share in 2018 owing to high disease
prevalence. However, chronic kidney disorder is expected to emerge with
the fastest CAGR of 9.7% from 2019 to 2025
- Institutional
sales emerged as the largest sales channel segment in 2018. However, the
online sales segment is projected to register the fastest CAGR during the
forecast years
- Asia Pacific is
among the prominent regions owing to huge geriatric population base and
high burden of chronic diseases
- Danone S.A.,
Nestle S.A., Abbott Laboratories, Fresenius Kabi, and Mead Johnsons &
Company, LLC are the major companies in the medical foods market
Access full
research report on global medical foods market:
www.grandviewresearch.com/industry-analysis/medical-foods-market
Sponsor Ads
Created on Sep 11th 2019 07:52. Viewed 314 times.